null - FindTrial

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2080224611

Enrollment

260

Registered

2019-03-26

Start date

2019-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

investigational material(s) Generic name etc : INN of investigational material : - Therapeutic category code : 636 Mixed biological preparations Dosage and Administration for Investigational material

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria:

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
efficacy	—

Secondary

Measure	Time frame
efficacy efficacy efficacy efficacy safety	—

Countries

Japan

Contacts

Public Contact; ;

;

cti-inq-ml@ml.mt-pharma.co.jp;;+81-6-6877-4812

Outcome results